NEW data from scientists and vaccine makers Moderna and Pfizer suggests that a newer, highly mutated variant of the virus that causes COVID-19 is not as alarming as some experts had feared when it was first detected several weeks ago.
Nicknamed "Pirola" on social media, the BA.2.86 Omicron subvariant is being tracked by both the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC).
What is new about COVID?
COVID infections and hospitalizations have been rising in the U.S., Europe and Asia, but are well below previous peaks. The weekly U.S. hospitalization growth rate slowed for three consecutive weeks in August, according to CDC data for the week ended Aug. 26.
As of Aug. 30, CDC said the BA.2.86 variant was detected in at least four U.S. states in people or wastewater. Delaware said it had detected a BA.2.86 infection at a hospital. The WHO has reported finding BA.2.86 in at least six countries.
According to CDC data, the EG.5 subvariant, a descendant of the Omicron lineage nicknamed "Eris" on social media that originally emerged in November 2021, accounts for about a fifth of current U.S. COVID cases.
A variant nicknamed "Fornax," officially FL.1.5.1, is the next largest at 14.5% of U.S. infections, and represents a growing share of East Coast COVID cases. A wide range of other variants account for smaller shares of the total, with BA.2.86 currently representing less than 1%.
Dr. David Dowdy, an infectious disease epidemiologist at Johns Hopkins Bloomberg School of Public Health, believes FL.1.5.1 will become the predominant COVID variant in the coming months, but he does not expect an infection wave like the one driven by Omicron last winter.
Dowdy suggested that the current surge in cases may be due to immunity from vaccination and infection wearing off some since the last surge.
What do scientists say about BA.2.86?
Scientists have been keeping an eye on BA.2.86 because it carries more than 35 mutations in key portions of the virus compared to XBB.1.5, the dominant variant through most of 2023.
The dramatic changes - on par with the genetic shift seen in the Omicron variant compared with its Delta predecessor - raised concerns that the new variant could cause a major surge.
Experiments testing versions of the virus in two U.S. independent laboratories suggest that is unlikely, said Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston, whose lab led one of the studies.
His team tested lab-made versions of the virus in people who were vaccinated or previously infected and found that antibodies against the variant were comparable or slightly higher than those against current circulating variants.
Experiments done in the lab of Dr. David Ho at Columbia University, as well as by teams in Sweden and China, had similar findings.
Will vaccines protect against new variants?
Barouch's studies also suggested that newly updated vaccines will raise antibody responses "to some extent" against all of the currently circulating variants, including BA.2.86.
Moderna said clinical data showed that its retooled COVID vaccine generated a nearly 9-fold increase in human antibodies that can neutralize BA.2.86.
Pfizer said on Wednesday that its updated COVID shot showed neutralizing activity against BA.2.86 and EG.5 in studies conducted on mice.
The updated shots are being reviewed by the U.S. Food and Drug Administration and are expected to be available this month.
Reuters
Sat Sep 09 2023
COVID infections and hospitalizations have been rising in the U.S., Europe and Asia, but are well below previous peaks. - REUTERS/Filepic
ERL, DK SCHWEIZER umum kerjasama sedia kerusi kulit premium untuk VIP KLIA Ekspres
Kerjasama itu merupakan pencapaian penting bagi kedua-dua syarikat dengan memanfaatkan kelebihan masing-masing.
Pendapatan lebih RM1 bilion, Ronaldo kekal atlet terkaya dunia - Forbes
Pemain berusia 39 tahun itu memperoleh pendapatan AS$260 juta (RM1.22 bilion) - meningkat daripada AS$136 juta (RM637 juta) - sejak 12 bulan lalu.
LKM sasar 10,000 hektar tanaman koko dalam lima tahun
LKM menggalakkan lebih ramai pemilik ladang kecil termasuk petani mengusahakan tanaman koko bagi mencapai sasaran keluasan tanaman komoditi itu.
Gunung berapi Ile Lewotolok Indonesia meletus, paksa Wings Air batal pendaratan
Sebuah pesawat Wings Air di laluan Kupang-Wunopito Lembata dengan 40 penumpang sepatutnya mendarat di lapangan terbang pada jam 11 pagi.
Jalan rosak di Johor berbaki 979 daripada 2,642 lokasi dikenal pasti
Sebanyak 1,075 kawasan jalan rosak telah dibaiki tahun lepas dan 588 lokasi lagi akan dibuat sepanjang tahun ini.
Imigresen Kelantan dakwa 15 pendatang di Mahkamah Sesyen Khas
Kesemua pendatang yang berusia antara 19 hingga 48 tahun itu ditangkap dalam Op Kutip sekitar Kota Bharu dan Bachok pada 3 Mei.
Semakan lengkap industri pertengahan kewangan sedang dijalankan - BNM
Kajian semula yang lebih menyeluruh terhadap industri pengantara kewangan sedang dijalankan, kata Penolong Gabenor Bank Negara Malaysia.
Piala FA 2024: Laluan mudah buat juara bertahan JDT
Melalui undian, JDT dilihat meraih lawan mudah dengan mengetuai 12 lagi pasukan Liga Super serta tiga pasukan daripada Liga A1 Semi Pro.
Dua wanita cedera, kereta terbalik dalam longkang di Lebuhraya WCE
Empat mangsa dalam kereta itu merupakan dua wanita dewasa, seorang lelaki dewasa dan seorang kanak-kanak perempuan.
Menteri China, Liu Jianchao bertemu pegawai kanan PKR diketuai Nurul Izzah
Malaysia sangat mementingkan hubungan dengan China dan pencapaian luar biasa China dalam pembangunan ekonomi dan sosial amat mengagumkan.
Persiapan Sarawak untuk RMK13 akan bermula tahun ini - Abang Johari
Persiapan Sarawak untuk RMK13 akan dimulakan tahun ini dengan tumpuan utama untuk melaksanakan fasa kedua PCDS 2030.
Kerajaan jamin sediakan rawatan kesan sampingan vaksin COVID-19 termasuk AstraZeneca - Dzulkefly
Kerajaan memberi jaminan akan menyediakan rawatan susulan bagi penerima vaksin COVID-19 termasuk AstraZeneca yang terbukti mengalami kesan sampingan.
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
Isu tunggakan cetakan MyKid bakal selesai Julai ini - JPN
Isu cetakan MyKid yang tertunggak akibat masalah perolehan bekalan mikrocip semasa pandemik COVID-19 lalu dijangka dapat diselesaikan pada Julai ini secara berperingkat di seluruh negara.
Program Jana Wibawa dilaksana selepas dapat persetujuan Jemaah Menteri - Saksi
Mahkamah Sesyen di sini hari ini diberitahu bahawa cadangan mengenai Jana Wibawa telah dibawa ke mesyuarat untuk pertimbangan sebelum Jemaah Menteri memutuskan supaya program itu diteruskan pada 2020.
Kelaparan akut jejaskan 281.6 juta orang tahun lepas - PBB
Tahap bahaya kelaparan akut menjejaskan 281.6 juta orang tahun lepas, tahun kelima berturut-turut bahawa ketakjaminan makanan semakin memburuk.
Hamilton optimis kedudukan lebih baik di GP China
Lewis Hamilton melihat potensi kedudukan yang lebih baik dalam saingan Grand Prix yang kembali ke China buat pertama kali dalam tempoh lima tahun, hujung minggu ini.
'Selfish!' - Fasha Sandha sedih raya di Perlis tak jadi gara-gara dijangkiti COVID-19
Fasha berkata dia mula melakukan pemeriksaan COVID-19 selepas berasa tidak sihat badan dan mengalami bersin tidak henti sejak Raya pertama.
Kes COVID-19 catat penurunan ketara pada ME 14/2024 - KKM
Jumlah kes COVID-19 menurun 97.1 peratus kepada 493 kes pada Minggu Epidemiologi ke-14 (ME 14/2024) iaitu bagi tempoh 31 Mac hingga 6 April lepas berbanding 17,256 kes pada ME 1/2024.
China jadikan pengalaman pencegahan COVID-19 untuk hadapi pandemik masa depan
China akan menjadikan pengalaman dalam pencegahan dan kawalan COVID-19 untuk membuat persediaan yang lebih proaktif untuk menghadapi pandemik masa depan seperti "Penyakit X".